An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer
Haiyun Wang(Tobacco Research Institute), Jens Köhler(Dana-Farber Cancer Institute)
Cited by 31
Related Papers
Quantitative source apportionment, risk assessment and distribution of heavy metals in agricultural soils from southern Shandong Peninsula of China
|The Science of The Total Environment|2021|230
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
|Cancer Cell|2022|101